Ovarian hypertension: polycystic ovary syndrome. - Wikidata - awgldk - TriplyDB

Ovarian hypertension: polycystic ovary syndrome.

Ovarian hypertension: polycystic ovary syndrome.

http://www.wikidata.org/entity/Q35660296

about

Risk of psychiatric disorders following polycystic ovary syndrome: a nationwide population-based cohort study Epidemiology, diagnosis, and management of polycystic ovary syndrome An Association Study between INSR/NsiI (rs2059806) and INSR/PmlI (rs1799817) SNPs in Women with Polycystic Ovary Syndrome from West Azerbaijan Province, Iran Predictors of subclinical cardiovascular disease in women with polycystic ovary syndrome: interrelationship of dyslipidemia and arterial blood pressure.Liraglutide improves hypertension and metabolic perturbation in a rat model of polycystic ovarian syndrome.Weight loss for women with and without polycystic ovary syndrome following a very low-calorie diet in a community-based setting with trained facilitators for 12 weeks.Regulation of Blood Pressure, Appetite, and Glucose by CNS Melanocortin System in Hyperandrogenemic Female SHR.Relationship between IL-17 serum level and ambulatory blood pressure in women with polycystic ovary syndrome.Polycystic ovary syndrome as a paradigm for prehypertension, prediabetes, and preobesity.Cardiovascular risk factors and events in women with androgen excess.Current aspects of polycystic ovary syndrome: A literature review.Aspects of Cardiometabolic Risk in Women with Polycystic Ovary Syndrome.Hyperandrogenemia reduces endothelium-derived hyperpolarizing factor-mediated relaxation in mesenteric artery of female rats.Genetic association study from North India to analyze association of CYP19A1 and CYP17A1 with polycystic ovary syndrome.Hypertensive Disorders in Pregnant Women Receiving Fertility Treatments.Effects of body mass index on the outcomes of in vitro fertilization in Chinese patients with polycystic ovary syndrome: a retrospective cohort study*.

P2860

Q33591300-4E6043D3-440A-415C-9954-388CCD02505E Q34658641-A7ADA0B3-E62C-46F1-A5E6-F28A90B153CC Q35276405-AEB4BCFA-851A-42E8-BF83-C79434D994C5 Q35297432-37406CE5-AA33-4E1E-887E-00C9D3F65CE5 Q35641060-BC7E5F3C-2958-4A9D-90AF-C7C7342188B0 Q36176816-B56FEDFC-980B-41E6-B34F-99475601C8EC Q36991746-E45A3F7C-01D7-4EA9-8E52-5CEDE388A8BD Q37410552-66558F9F-08F8-43E6-91D1-A54BD6E350BF Q38258968-664CE82F-BAFC-49CB-B870-48218CEDE576 Q38272385-20793889-0260-43E7-831C-5982AA699F79 Q39046122-14F81D38-E5EE-453B-85E8-9C69F7519B38 Q40252855-F786A3C7-657A-4CA4-9CC5-4F83111BC463 Q47769274-011EA0B0-6D6D-4DEF-9B15-558BB14EF104 Q52346831-B3785FFC-7BA3-465A-BFE7-636A39095FAA Q55358404-AC615E28-D807-4C44-A8BF-0BE29E1B0DA3 Q55691057-12988547-8400-4DA4-8B53-124141400BCA

P2860

Ovarian hypertension: polycystic ovary syndrome.

http://www.wikidata.org/entity/Q35660296

description

2011 nî lūn-bûn

@nan

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

2011年论文

@zh

2011年论文

@zh-cn

name

Ovarian hypertension: polycystic ovary syndrome.

@ast

Ovarian hypertension: polycystic ovary syndrome.

@en

type

label

Ovarian hypertension: polycystic ovary syndrome.

@ast

Ovarian hypertension: polycystic ovary syndrome.

@en

prefLabel

Ovarian hypertension: polycystic ovary syndrome.

@ast

Ovarian hypertension: polycystic ovary syndrome.

@en

P1433

Q35660296-2519BCD9-4B32-4A4D-B09C-6F0EDC1B5C9F

P1476

Q35660296-559DDBD1-BCB5-4027-85C7-900F8FB36093

P2093

Q35660296-4B380BBD-0988-43FB-8EE0-0DC29C32F5F1

Q35660296-CD8B607F-ADFA-4886-BBEA-FE4BE30394A2

Q35660296-F7381530-416C-4516-A897-8DA096319222

P2860

Q35660296-044E73FB-4AFB-434B-9CAA-A3B73953CC33

Q35660296-054DF452-E0C9-49A6-960C-6A21BCB5CE62

Q35660296-07C35CA4-C03C-492C-887C-2EC76FECBA30

Q35660296-0852A888-2C84-4B6C-B7A8-2CC56FC4ABD3

Q35660296-08BD35F1-A223-49D5-B27D-7C905FFCEF80

Q35660296-0A10BB2D-72E2-433F-87CC-3F43E7024B4E

Q35660296-0A43390E-4064-4084-878C-5237663C0982

Q35660296-0D37019C-9E31-4DEA-930F-5014F5E386C8

Q35660296-0E56FA1C-9CEC-4FFF-B9B2-6F3806311531

Q35660296-0E801AA4-0E63-4244-A471-D940D04FEF9A

P304

Q35660296-3737434F-ADB1-445D-9D7B-B700C3CF7516

P31

Q35660296-07C9C338-C189-4E8A-9E9D-8C0E767DABD3

P356

Q35660296-6DB9E123-E93E-4A5A-AC02-2DDD7D97C815

P433

Q35660296-542DF78D-6D11-447C-8C30-7C75BD8059A1

P478

Q35660296-FBC41B77-510A-4487-A65F-BF2A1F571284

P577

Q35660296-0D88A3B0-245E-45BF-9F18-27105FAE597A

P5875

Q35660296-4B7F7FB6-28F3-4266-9E09-7962A7E331B9

P698

Q35660296-5F2A9D9F-E0B6-4D96-9309-C1B5D5F8F6A0

P921

Q35660296-A869CD85-EA17-4E9B-9AD0-DF4D81273116

P932

Q35660296-7CE36214-2110-4AC3-9CD7-59C17650CF04

P356

J.ECL.2011.01.009

P1433

Endocrinology and Metabolism Clinics of North America

P1476

Ovarian hypertension: polycystic ovary syndrome.

@en

P2093

Andrea Dunaif

http://www.w3.org/2001/XMLSchema#string

Ellen Seely

http://www.w3.org/2001/XMLSchema#string

Rhonda Bentley-Lewis

http://www.w3.org/2001/XMLSchema#string

P2860

Laparoscopic drilling by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome

Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

Insulin resistance and the polycystic ovary syndrome: mechanism and implications for pathogenesis

Polycystic Ovary Syndrome (PCOS): Arguably the Most Common Endocrinopathy Is Associated with Significant Morbidity in Women

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation

Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

Neuroendocrine aspects of polycystic ovary syndrome.

Polycystic ovarian syndrome: evidence that flutamide restores sensitivity of the gonadotropin-releasing hormone pulse generator to inhibition by estradiol and progesterone.

P304

433-49, ix-x

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.ECL.2011.01.009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

40

http://www.w3.org/2001/XMLSchema#string

P577

2011-06-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51120473

http://www.w3.org/2001/XMLSchema#string

P698

21565677

http://www.w3.org/2001/XMLSchema#string

P921

polycystic ovary syndrome

P932

3253555

http://www.w3.org/2001/XMLSchema#string